Contract Manufacturing

Roche and its Genentech unit today announced plans to invest more than $700 million in a new manufacturing facility in the U.S. The company plans to build a new 700,000 square-foot, state-of-the-art drug manufacturing plant in Holly Springs, North Carolina. It expects to add more than 400 high-wage manufacturing jobs once operational, plus more than…

Amgen announced that it plans to invest $900 million to expand its pharmaceutical manufacturing facility in Ohio. The expansion brings the total number of jobs created to 750. Amgen’s total investment in Central Ohio now eclipses $1.4 billion. “Amgen has been a leading U.S.-based manufacturer of biologic medicines since 1988. Today’s investment reinforces our ongoing…

Roche announced plans to invest $50 billion in the U.S. over the next five years to boost manufacturing and R&D. Basel, Switzerland-based Roche says the investments strengthen its U.S. footprint and should create more than 12,000 new jobs. That includes nearly 6,500 construction jobs, plus 1,000 jobs at new and expanded facilities. As part of…

Thermo Fisher Scientific announced today that it plans to invest an additional $2 billion in the U.S. over the next four years. The company said its investment should strengthen American innovation, manufacturing and economic competitiveness in the life sciences sector. It also comes as a number of companies consider investing in U.S. infrastructure amid potential…

Fujifilm Diosynth Biotechnologies, a major contract development and manufacturing organization (CDMO), has entered into a 10-year manufacturing supply agreement with Regeneron Pharmaceuticals, valued at over $3 billion. The deal has the Fujifilm subsidiary providing U.S.-based manufacturing for Regeneron, with planned expansions at Fujifilm’s large-scale biopharmaceutical manufacturing facility in Holly Springs, North Carolina. The Holly Springs…

BDD announced today that it opened a new 122-square-meter GMP manufacturing facility at BioCity near Glasgow. The company opened its facility after two years of development following a successful inspection by the Medicines and Healthcare products Regulatory Authority (MHRA) last month. A £2 million funding round from existing investors facilitated the development of the state-of-the-art…

Ashland announced that it completed a $10 million expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil. The company plans to mark the occasion with a ribbon-cutting ceremony tomorrow, April 4. This investment significantly expands Ashland’s pharmaceutical footprint in the region and capabilities to meet increasing market demand for coated tablets in Latin America and…

Qosina announced today that it entered into a collaboration with AdvantaPure to enhance its selection of solutions for pharmaceutical manufacturing. AdvantaPure, the high-purity products division of NewAge Industries, anticipates and satisfies the evolving needs of the pharmaceutical and biopharmaceutical manufacturing industries. As an official distribution partner for AdvantaPure, Qosina now expands its tubing portfolio with…

Emergent BioSolutions announced today that it entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility. The company agreed to sell the plant to Syngene, a leading global CRDMO, for a total value of $36.5 million. The plant includes manufacturing, laboratory, warehousing and office space, plus multiple monoclonal antibody (mAbs) manufacturing lines. Syngene…

Getinge recently launched its DPTE-FLEX manual, externally openable port for pharmaceutical manufacturing. The company designed the port to enhance safety, efficiency and compliance. It allows for secure, gloveless transfers to reduce human intervention and contamination risks. “The external handles of the DPTE-FLEX perform dual functions — unlocking/locking and opening/closing – all accessible from outside the…